Megafacia Tablet 1 Milligram (Finasteride)

Adult dose

Generally, dose 1 mg orally once daily as Finasteride, which can be taken regardless of meals. Typically, treatment effects can be seen after taking it for more than 3 months, and continuous intake is recommended for maintaining treatment efficacy. Treatment duration and efficacy should be continually evaluated. If interrupted, the treatment effects will dissipate within 12 months.

This medication should not be administered to children or women. Women who are pregnant or may become pregnant should not touch broken tablets of this medication as the components can be absorbed through the skin and affect a male fetus. During the course of this medication, changes in mental status including depressive moods, depression, or suicidal thoughts may occur, and patients should immediately consult a healthcare professional if such symptoms arise. Pregnant women or women of childbearing potential, patients allergic to this medication or its components, patients with certain genetic lactulose intolerance, or those with allergies to soybean oil, beans, or peanuts should not take this medication. Patients with liver function issues or metabolic disorders such as hyperlipidemia, diabetic dyslipidemia, pancreatitis should use this medication cautiously. This medication may cause side effects related to sexual function, including decreased libido, erectile dysfunction, and ejaculatory disorders. However, these side effects generally resolve after discontinuation of the medication. This medication may influence the risk of prostate cancer; thus, men over 55 should undergo regular examinations and consult their healthcare providers. If any changes such as breast pain, enlargement, lumps, or nipple discharge occur during treatment, contact a physician immediately. No significant interactions with other medications have been reported, but patients should inform their healthcare providers about any other medications they are taking. Animal studies during pregnancy have confirmed that this medication can cause genital abnormalities in male fetuses; therefore, women should avoid taking it. This medication is not administered to breastfeeding women, and its safety and efficacy have not been established in children. There is no need for dosage adjustment in the elderly, but the effectiveness in this population has not been thoroughly studied. During treatment, results of blood tests, particularly interpretation of prostate-specific antigen (PSA) levels should be monitored carefully. There is no specific treatment for overdose, but serious adverse reactions are rarely reported in clinical trials with high doses. Store this medication in a closed container away from children and do not transfer it to another container. Long-term use has been reported as having a low risk of carcinogenicity or mutagenicity, although rare occurrences of male breast cancer should be noted. This medication may affect reproductive function, but most recover after discontinuation; thus, consulting a healthcare provider upon the appearance of any unusual symptoms is important.

Serious side effects

Hives, angioedema (swelling of lips, tongue, throat, and face), rash, itching, depression, suicidal thoughts, lumps, pain and nipple discharge, breast enlargement, tenderness and neoplasia, severe rashes with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, sudden and severe headaches, lightning headaches, seizures, confusion, vision changes, paralysis

Mild side effects

• Decreased libido
• erectile dysfunction
• ejaculatory disorder
• breast tenderness
• muscle pain
• fatigue
• anxiety
• dizziness
• headache
• palpitations

This medication should be stored in a closed container to protect it from air and moisture. Additionally, for maintaining the effectiveness of the drug, it should be stored at a cool temperature between 15 to 30 degrees Celsius.

Appearance

Brownish-yellow, biconvex, octagonal film-coated tablet

Package unit

Domestic - 30 tablets/PTP [(10 tablets/PTP*3)]